Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate and Kidney Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02457715
What this trial is testing

Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis

Who this might be right for
Prostate CancerRenal CancerBrain Cancer+1 more
Duke University 40
Testing effectiveness (Phase 2)Study completedNCT02136121
What this trial is testing

Prospective Investigation of Robotic Single-port System

Who this might be right for
Prostate and Kidney Cancer
Intuitive Surgical 19
Testing effectiveness (Phase 2)Looking for participantsNCT07072728
What this trial is testing

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Who this might be right for
Adjustment DisorderAdjustment Disorder With Anxious MoodCancer+8 more
Psyence Australia Pty Ltd 87
Testing effectiveness (Phase 2)Looking for participantsNCT03972657
What this trial is testing

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 345
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT01174368
What this trial is testing

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T

Who this might be right for
Prostate Cancer
The Rogosin Institute 1
Not applicableUnknownNCT02186925
What this trial is testing

A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Who this might be right for
Kidney CancerProstate CancerBladder Cancer
Meir Medical Center 1,000
Not applicableStudy completedNCT02375776
What this trial is testing

Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention

Who this might be right for
Renal Cell CancerProstate CancerEffects of Chemotherapy
Massachusetts General Hospital 84
Not applicableStudy completedNCT01528774
What this trial is testing

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

Who this might be right for
Melanoma
Wolfram Samlowski 150
Not applicableStudy completedNCT04755452
What this trial is testing

The Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cancer Surgery.

Who this might be right for
Acute Kidney InjuryPneumoperitoneumKidney
Aalborg University Hospital 100
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Early research (Phase 1)Study completedNCT00381173
What this trial is testing

ZYC300 Administered With Cyclophosphamide Pre-Dosing

Who this might be right for
Breast CancerOvarian CancerProstate Cancer+2 more
Eisai Inc. 22
Not applicableActive Not RecruitingNCT00579514
What this trial is testing

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

Who this might be right for
Breast CancerBladder CancerKidney Cancer+4 more
Memorial Sloan Kettering Cancer Center 21,081
Testing effectiveness (Phase 2)Looking for participantsNCT07285044
What this trial is testing

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Who this might be right for
AmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more
Mayo Clinic 27
Not applicableUnknownNCT06363123
What this trial is testing

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Who this might be right for
Lung CancerBreast CancerColorectal Cancer+10 more
Beijing Friendship Hospital 2,700
Not applicableStudy completedNCT03064308
What this trial is testing

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

Who this might be right for
Impaired CognitionQuality of LifeSurgery+7 more
University of Nottingham 11
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Testing effectiveness (Phase 2)Ended earlyNCT01650350
What this trial is testing

Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer

Who this might be right for
MelanomaProstate CancerRenal Cancer
Brown University 7
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Next Page